The Contact Point of the FAMHP receives and centralizes information concerning facts that could constitute an infringement of article 10 of the Law on Medicinal products, including infractions of the visa procedure.

You can find more information concerning the Contact-Point in the Royal Decree of June 10, 2006 and in the Communication nr. 572 of October 28, 2010.

Mdeon is not competent to do a posteriori control. For questions concerning control, please contact thus the “Contact-Point” of the authority:

afmpsFederal Agency for Medicines and Health Products
Galileelaan 5/03
1210 Brussels